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MARSH, J. T., G. SCHUBARTH, W. S. BROWN, W. RIEGE, R. STRANDBURG, D. DORSEY, A. MALTESE AND D. KUHL. 
PET and P300 relationships in early Alzheimer's disease. NEUROBIOL AGING 11(4) 471--476, 1990.--The P300 (P3) wave of the 
auditory brain event-related potential was investigated in patients with probable Alzheimer's disease to determine whether P300 latency 
discriminated these patients from controls and whether prolonged P300 latency correlated with rates of brain glucose m tabolism as 
measured by Positron Emission Tomography. P300 latency was prolonged by more than 1.5 standard deviations from age expectancy 
in 14 of 18 patients, but none of 17 controls. In these subjects P300 latency was shown to be inversely correlated with relative 
metabolic rates of parietal and, to a lesser extent, temporal and frontal association areas, but not with subcortical areas. 
Alzheimer's disease Event-related potentials P300 Positron Emission Tomography 
THE latency of the P300 (or P3) component of the brain 
event-related potential (ERP) has been demonstrated to increase 
with aging in normal adults (2, 4, 13, 34, 38, 41). A number of 
studies have also shown P300 latency to be significantly prolonged 
in dementia of varying etiology. Depending on the study, from 50 
to 80% of demented patients have P300 latencies prolonged more 
than 2 standard eviations beyond that which would be predicted 
by the linear regression f P300 on the age of nondemented a ults 
(3, 12, 14, 17-19, 48). Further, P300 latency has been shown to 
track changes in mental status in patients whose confusional state 
or dementing illness varied in severity over time, increasing as 
dementia worsens and decreasing with remission (16). However, 
some investigators have questioned whether this measure is 
sufficiently sensitive to hold any promise for clinical diagnostic 
utility (35). 
P300 latency is a measure of cognitive processing time (8, 30, 
47) and increases with task difficulty (5, 10, 15, 27, 44, 45). 
However, the neural substrates of abnormal P300 latency are 
unknown. For example, in patients with probable Alzheimer's 
disease, it is not known whether or not the abnormally prolonged 
P300 latency in the majority of these patients is associated with 
functional deficits in specific brain regions. The opportunity to 
address this question arose when brain event-related potentials 
were obtained from patients with early probable Alzheimer's 
disease who were participating in a larger study to determine PET 
markers of probable Alzheimer's disease (pAD). Glucose utiliza- 
tion indexed by the uptake of (F-18) 2-fluoro-2-deoxy-glucose has
been shown to be sensitive to focal changes in brain function 
associated with degenerative diseases of the nervous system (28, 
37, 42). 
This report demonstrates not only the sensitivity of P300 
latency to early stages of pAD, but also a strong relationship 
between P300 latency and metabolic rate of parietal, frontal, and 
temporal cortical regions which are reduced in varying degrees in 
pAD (7, 11, 29, 43). 
METHOD 
Eighteen individuals with early probable Alzheimer's disease 
were compared with 17 age-matched healthy, nondemented indi- 
viduals in this study, pAD subjects were selected from a much 
larger group of over 300 individuals referred from the community 
on the basis of criteria characteristic of possible arly Alzheimer's 
disease. Patients were included in the study if they met the 
following criteria: between 50 and 75 years of age, gradual and 
progressive loss of memory and cognitive function with inconspic- 
uous onset, normal consciousness, and impairment in 3 of 5 
cognitive functions (orientation, judgement and problem solving, 
social functioning, home and hobbies, personal care). Patients and 
controls were excluded from the study if there was evidence of any 
other neurological disorder. Information for diagnosis and inclu- 
sion in this study was obtained using a three-stage diagnostic 
process: 1) Preliminary Evaluation: Extended interview of subject 
and family members regarding education and occupational back- 
ground, and medical and neurological history. Administration f
several scales and tests including the Mini-Mental State, WAIS 
Digit Span, Word Generation, Zung Depression Scale, Blessed 
Dementia Scale, and Hachinski Scale. 2) Psychiatric, Neuropsy- 
chological and Neurolinguistic Evaluation: Psychiatric interview; 
neuropsychological evaluation of memory, intelligence, problem 
solving, abstraction and spatial relations; neurolinguistic evalua- 
tion of comprehension, expression, word knowledge, and writing; 
and completion f a Clinical Dementia Rating (23) based on all the 
above data. 3) Laboratory Tests and Complete Neurological 
Exam: Neurological examination i cluding mental status, systems 
review, and vital signs; review of laboratory measures; and 
completion of second Hachinski Scale and Clinical Dementia 
Rating based on these data. 
Diagnosis of pAD was confirmed on the basis of subsequent 
annual follow-up examinations for up to 4 years after the initial 
study. These diagnostic tests served to establish the presence and 
severity of dementia, and to rule out diagnoses other than 
Alzheimer's disease. Out of an initial group of 32 patients 
originally diagnosed as questionable AD, the 18 subjects of 
this study were confirmed to be probable AD at follow-up 1 to 2 
years later. Basis for post hoc elimination from this study was 
evidence of pseudodementia, atypical course, and indications of 
multiple infarct. Twelve of the 18 pAD patients and all 17 controls 
were also included in a longitudinal study of P300 latency in 
dementia (1). 
Under the criteria of the Clinical Dementia R ting, 9 patients 
were given a rating of CDR 0.5 (questionable dementia) and 9 
patients a CDR of 1.0 (mild dementia) at the time of original 
examination. Patients in this study had a mean age of 65.2---5.8 
years (standard deviation) and a mean Mini-Mental State [MMS; 
(8)] score of 24.7 ± 1.3. The 17 age-matched control persons had 
a mean age of 64.4__.6.7 and a mean MMS of 29.6±0.7. 
Each patient and control underwent PET scans of cerebral 
glucose utilization involving the injection of (F-18)-labeled 2- 
fluoro-2-deoxy-glucose (FDG) (37). Local cerebral metabolic 
utilization of glucose was measured following Sokoloff's model 
(46). This study utilized a third generation tomograph (NeuroEcat, 
CTI Inc., Knoxville, TN), which has image resolution of 9.5 mm 
in the plane of section and 12.4 mm in the axial direction. Subjects 
remained in the resting state (eyes and ears open) on the gurney of 
the tomograph after injection of 5-10 mCi FDG intravenously. 
Arteriolized blood was sampled and, after 40 min, multiple scans 
were taken at 0 degrees to the orbital-meatal lines and were 
completed after anaccumulation f 2-3 million counts per image. 
Image values were converted to regional cerebral metabolic rate of 
glucose utilization (rCMRGlu) based on the model of Phelps and 
Huang using constants derived from young adults (36). These 
rCMRGlu (in micromoles/min/100 grams) did not significantly 
differ from those of a group of old persons (20). If the rCMRGlu 
is a measure of the function of a specific region, then the 
cross-sectional image of the brain FDG metabolism presents a 
functional map of brain activity in regions of interest. 
Based on hypotheses concerning possible neural systems which 
might modulate P300 latency (parahippocampal region), together 
with evidence regarding decreased function of temporal, parietal 
and to a lesser extent frontal cortex in moderately demented 
Alzheimer's patients (11, 42, 43), we selected posterior parietal, 
temporal, parahippocampal and frontal PET measures recon- 
structed from multiple scans in the horizontal plane. Relationships 
between P300 latency and subcortical function were investigated 
using a mean of PET values from the caudate and thalamus regions 
(caudate-thalamus). In order to control for individual differences 
in overall brain metabolic rate and more specifically observe 
distributions of neural activity, PET measures from areas of 
interest were expressed as a ratio of regional to cerebellar 
metabolic rate. Cerebellar metabolism i  known to be little 
affected in the early stages of Alzheimer's type dementia (25). 
For P300 recording, individuals istened to a series of moderate 
intensity, low pitched tones (250 Hz, 70 dB SPL, 55 msec in 
duration, 1.5 sec ISI) occasionally and randomly replaced by a 
higher pitched, louder tone (450 Hz, 84 dB, occurring on 20% of 
trials). Subjects were asked to keep a cumulative count of the 
target tones (32 in all). 
ERPs were recorded from midline parietal (Pz), central (Cz) 
and frontal (Fz) scalp positions referenced to the left ear, the right 
ear serving as ground. EEG was amplified with gain of 14,140 and 
filtered at 0.1 to 50 Hz (3 dB down). Responses were digitized for 
computer averaging at 250 samples per second. ERPs were 
averaged over a one-second epoch, including 100 msec of pre- 
stimulus baseline and 900 msec of ERP. Automatic artifact 
rejection of single trial responses was accomplished via an 
amplitude window set independently foreach subject. Amplitude 
criteria were set to reject large voltage deflections such as 
eye-movement and eye-blink artifact apparent i  simultaneous 
EEG records. 
The P300 wave was identified as the largest positive wave 280 
msec or longer stimulus onset, present in responses to the target 
(counted) stimuli and absent (or considerably attenuated) in 
responses to the frequent (noncounted) stimuli. P300 latency was 
measured at Pz, using the other electrodes to helpidentify the 
P300 wave. Latency was measured from the midpoint of a 
horizontal ine drawn between the rise and fall of the wave at 
approximately the 2/3amplitude level. Since P300 latency in- 
creases in a systematic way with age, latency was expressed in 
standard eviation units (Z-scores) from the P300 latency/age 
regression line calculated from a group of 57 normal individuals 
over the age of 50 previously run in our laboratory using the same 
stimulus and recording parameters (4). The regression formula 
used to calculate the expected normal P300 latency in milliseconds 
was: 
expected = (age x 2.05) + 199 
Z-scores were calculated using the following formula: 
Z = (actual - expected)/25.3 
Statistical analysis of the data utilized t-tests, Pearson correla- 
tion, multiple r gression and stepwise discriminant function anal- 
ysis as appropriate. Tocalculate the .01 significance level adjusted 
for the number of correlations performed (shown as the dashed line 
in Fig. 3), a critical r-value was obtained by dividing the 
significance level of .01 by the number of comparisons. This 
yielded a normalized probability density value. To make this a 
two-tailed test of significance, that value was halved and the 
corresponding t-value obtained. The t-value was converted into a 
critical r-value using a formula given on p. 661 of (21). 
CONT: P3<340 msec CONT: P3>340 msec PRO: P3<40~ msec PRD: P3>400 msec 
Cz 
Fz 
N1 
. . . . . . . . . .  f . . . . . . . . . .  I . . . . . . . . . .  [ . . . . . . . . .  
1 sac  
FIG. 1. Cross-subject mean ERPs based on a P300 latency median split of subjects in each group: Controls with P300 latency less than (N = 9), and greater 
than (N = 8), 340 msec; pAD subjects with latencies less than (N = 9) and greater than (N = 9) 400 msec. Responses to the frequent (dashed) and target 
(solid) stimuli are superimposed for each of 3 electrode locations (Pz, Cz, Fz). The P300 (labeled as "P3") is evident as the positivity (upward deflection) 
beginning approximately 250 msec after the tone onset (vertical marker on the time scale). Since amplitude for each subject was normalized before creating 
these cross-subject averages, amplitude differences between groups are not represented. However, frequent/rare amplitude relations and scalp topography 
(Pz, Cz, Fz) are preserved. Normalization of amplitude for this figure was done to allow equal contribution of each subject o the cross-subject mean 
waveforms and, thus, more precise representation of the mean latency of components. Time scale tick-marks occur every 100 msec. 
RESULTS 
Figure 1 presents examples of ERPs from 2 normal and 2 
demented individuals, illustrating longer latencies for the pAD 
subjects. P300 latencies in standard eviation units (Z-scores) for 
all normal (CDR=0)  and pAD patients (CDR 0.5 and 1.0) are 
presented in Fig. 2. The P300 latency of all 17 normal subjects fell 
within _ 1.5 standard eviations of our P300 latency/age regres- 
sion line. However, 14 of 18 pAD patients had P300 latencies 
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FIG. 2. P3 latency data converted to Z-scores for all subjects. From the 
left, columns are 17 normal controls (CDR = 0.0), 9 questionable d mentia 
(CDR=0.5), and 9 mild dementia (CDR= 1.0) AD patients. The dashed 
line represents he maximum Z-score value for the normal controls of this 
study. Only four of 18 patients fall within the range of normal subjects. 
beyond the range of P300 latencies (in Z-scores) for the normal 
group. There was a highly significant difference between ormal 
and pAD subjects in both mean P300 latency Z-score ( t=4.86,  
p<0.0001; normal mean=-0 .08 ;  pAD mean=3.37)  and in 
actual P300 latency ( t=4.95,  p<0.0001; normal mean=335 
msec; pAD mean=431 msec). 
In order to test the ability of P300 latency to distinguish 
between early AD patients and normal controls, a stepwise 
discriminant function analysis was performed with P300 latency 
Z-score and PET ratio values as variables. The first variable 
entered was P300 latency Z-score, which yielded a 89% correct 
classification with no controls classified as AD, and four AD 
misclassified as controls. When the Parietal/Cerebellum metabolic 
measure was added to the discriminant function, the correct 
classification i creased to 91.4% with one false positive, i.e., one 
control classified as AD. This level of discrimination is notable in 
view of the fact that the patients in this study were initially 
classified (i.e., at time of P300 and PET measurement) as 
questionable Alzheimer's disease, having symptomatology char- 
acteristic of the very early stages of dementia. 
While the groups differed significantly in P3 latency, no 
difference was seen for the earlier N1 and P2 components. N1 
latencies for the pAD and control groups were 99.3 msec and 99.5 
msec, respectively ( t=0.06,  p=ns) .  P2 latencies were 177.3 
msec and 182.2 msec ( t=0.88,  p=ns) .  
Within the pAD group, P300 latency did not differ significantly 
according to CDR grouping (CDR 0.5; mean Z-score=3.12, 
mean latency=420 msec; CDR 1.0; mean Z-score=3.57, mean 
la tency-440 msec). A relationship was found between P300 
latency and scores on the Mini-Mental State Exam. For the 
combined group of patients and normals, there was a significant 
correlation between P300 latency and MMS scores (MMS vs. 
P300 Z-score, r=- .58 ,  p<0.001; MMS vs. P300 latency, 
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FIG. 3. Correlation fP3 latency (in Z-scores) with PET measures for the combined pAD 
and control groups. From left to right, bars represent correlations with the following PET 
measures: global metabolic rate; parietal metabolic rate divided by cerebellum metabolic 
rate (Pt/Cb); temporal divided by cerebellum (Tmp/Cb); frontal divided by cerebellum 
(Ft/Cb); parahippocampal divided by cerebellum (PHp/Cb); caudate-thalamus divided by 
cerebellum (CTh/Cb); and frontal divided by parietal (Ft/Pt). Al correlations are graphed 
as absolute values. (As predicted, all correlations are negative with the exception ofFt/Pt, 
which is positive.) The dashed line represents the two-tailed p<0.01 significance level, 
adjusted for multiple comparisons, as described in the Method section. 
r = - .61, p<0.001). However, within the pAD group itself, there 
was not a significant correlation between P300 Z-score and MMS. 
Thus, while P300 latency was indicative of the presence of pAD, 
even in the early mild phases, it was not consistently related to the 
degree of dementia s indexed either by CDR or MMS scores. 
Correlations were calculated for the present data between the 
P300 latency Z-score vs. PET measures for various cortical and 
subcortical areas in the combined pAD and control group (Fig. 3). 
P300 latency was not correlated with global metabolic rate or with 
that of caudate-thalamic regions. However, significant correla- 
tions were observed in metabolic rates of cortical regions ex- 
pressed as ratios of cerebellar metabolism. The parietal ratio 
showed the most significant negative correlation ( r=- .58 ,  
p<0.001; see Fig. 4), i.e., lower FDG uptake was associated with 
longer P300 latency. Progressively lower but significant negative 
correlations were found with frontal and temporal ratios. When 
combined into a multiple regression equation, PET measures 
accounted for a significant amount of variance in P300 latency 
Z-scores (Re=.501, F=3.87,  p<0.0001). The variance x- 
plained was primarily attributable to the Parietal/Cerebellum 
metabolic ratio (R 2= .335, F=4.79,  p<0.037). 
Because of the more rapid parietal, as compared to frontal, 
decrement incortical function in early Alzheimer's disease (11,29), 
we anticipated a positive correlation between the P300 latency 
Z-scores and a Frontal/Parietal PET ratio in these patients. This 
correlation was not significant. 
Relationships between PET ratios and P300 latency were also 
tested within the pAD group alone. P300 latency Z-score was 
correlated significantly with Frontal/Cerebellum etabolic ratio 
(r = - .49, p<0.02), but not with those from other brain regions. 
DISCUSSION 
The results of this study demonstrate hat P300 latency is one 
measure sensitive to the functional status of cerebral association 
cortex, especially the parietal region and, to a lesser degree, 
frontal and temporal areas. It is noteworthy that this association 
was observed in early stage AD patients and controls. 
The high rate of correct classification in this study (89%) as 
compared to others in the literature [(14), 80%; (3), 72%; (48), 
83%; (17), 79%; (35), 31%] may in part reflect the extensive 
selection procedures, including thorough screening for other 
possible etiologies of cognitive decline. Also contributing to 
successful discrimination was the strong association between P300 
latency and the functional status of the cortical tissue most at risk 
in early Alzheimer type dementia. Thus studies using mixed 
groups or other types of dementia, e.g., multiinfarct, Parkinson's, 
and Huntington's patients, have yielded lower discrimination 
rates, perhaps due to less consistent involvement of cortical 
association regions in these disorders. 
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FIG. 4. Scanerplot f the relationship between P3 Z-score and parietal 
metabolic rate divided by cerebellum metabolic rate for normal controls 
(solid diamonds) and pAD patients (open diamonds). The line represents 
the regression function: Pt/Cb rate = 1.084 - (0.049 × P3 Z-score). 
While P300 latency discriminated between early Alzheimer's 
patients and controls, it does not differentiate between question- 
able and mild stages of dementia (Fig. 2; CDR 0.5 and CDR 1.0). 
There is, however, evidence that P300 latency is sensitive to the 
degree of dementia when a wider range of cognitive decline is 
considered (4, 18, 31, 39). P300 latency, as a measure of 
perceptual processing speed, represents only one facet of the many 
cognitive abilities summarized in the CDR or MMS. While 
various mental bilities are relatively well correlated over broad 
functional ranges, within more narrowly defined groups, such as 
CDR 0.5 and 1.0, these abilities may not be strongly associated. 
An alternative hypothesis for the lack of association between P300 
latency and CDR or MMS in pAD patients would propose that 
P300 latency is more sensitive to individual differences in general 
cognitive ability than either CDR or MMS within the early stages 
of AD. 
The strong association of P300 latency with the functional 
status of parietal association cortex is consistent with what is 
known about both the cognitive processes related to P300 latency 
(i.e., perceptual recognition time), and those cognitive processes 
which depend heavily on the participation of the parietal cortical 
region (i.e., perceptual discrimination and recognition). Consid- 
erable evidence supports the notion that P300 latency is prolonged 
by increasing task difficulty in such a way as to require greater 
depth of stimulus processing (5, 8, 10, 15, 27, 30, 44, 45, 47). 
Since the importance of parietal cortex, particularly in the tempo- 
ral-parietal-occipital (TPO) region, in information processing is 
well established (6, 22, 26, 32, 33), the sensitivity of P300 latency 
to compromised functioning of this region is not surprising. 
Evidence is also accumulating linking P300 to some aspects of 
memory function (24, 40, 49). For example, Polich et al. (40) 
have reported an association between P300 latency and immediate 
memory of numbers in the Digit Span test in normal individuals. 
Significant correlations were found in the subjects of our study 
between P300 latency and a number of neuropsychological tests of 
memory function. Thus, prolonged P300 latency and decreased 
function in the TPO area may be associated with memory decline. 
Impaired memory is one of the earliest and most prominent 
features of Alzheimer type dementia. 
It should be emphasized that these data do not bear on the issue 
of the neural generators of the P300 wave. Rather, they reveal 
aspects of the neural systems required for the rapid and efficient 
information processing reflected in a short latency P300. Efficient 
processing in parietal cortex would, thus, be a necessary contrib- 
utor to the elicitation of a normal latency P300, which itself may 
be generated in other neural tissue. 
The dependence of P300 latency on the level of parietal obe 
functioning suggested in these data must be considered in the light 
of abnormally prolonged P300 latencies in patients with primarily 
subcortical neurological disorders, i.e., Parkinson's disease and 
Huntington's disease (18,19). In the case of these subcortical 
dementias, latencies of earlier components, particularly N1 and 
P2, are also delayed along with the P300. In Alzheimer's patients 
these early waves have normal latencies and the later P300 is 
specifically delayed (12). As indicated in the results, this was also 
the case for the pAD patients in this study. Thus, while delayed 
P300 latency in subcortical dementia might be characterized as a 
"downstream" effect of changes in earlier stages of processing, in 
Alzheimer's dementia P300 latency appears to be a more specific 
reflection of the integrity of the parietal cortex. 
Finally, we believe that these results bear on the possible 
clinical utility of a P300 latency measure. Our results suggest that 
P300 latency can be used as a one-directional clinical test in which 
normal latency cannot be said to rule out the presence of 
dementing illness, but prolonged latency would suggest a high 
probability of dementia. Although the relationship should be tested 
in other dementias, prolonged P300 latency, together with normal 
latency of earlier components, appears to be an index of the 
declining functional status of cortical association tissue, particu- 
larly of the parietal obe. Increase in P300 latency would thus be 
a reflection of the compromised status of a specific brain system, 
rather than type of dementing disease. 
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